Technical Information
| HTTP Status Code | 200 |
| HTTP Version | HTTP/1.1 |
| HTTPS | ✔ Available |
| IP Address | 15.197.225.128 |
|
ℹ 🔵 Missing Content Security Policy | CSP is not configured. It helps prevent XSS attacks and content injection. |
|
ℹ 🔵 No Compression | The server does not use Gzip or Brotli. Enable compression to reduce bandwidth usage. |
HTTP Status Code 200
HTTP Version HTTP/1.1
HTTPS ✔ Available
IP Address 15.197.225.128
ℹ 🔵 Missing Content Security Policy CSP is not configured. It helps prevent XSS attacks and content injection.
ℹ 🔵 No Compression The server does not use Gzip or Brotli. Enable compression to reduce bandwidth usage.
Redirect Chain
| # | URL | HTTP Status Code | Status |
| 1 | https://timeisnephrons.com:443 | 301 | HTTP/2 301 |
| 2 | https://LNknowthesigns.com | 301 | HTTP/2 301 |
| 3 | https://www.lupkynispro.com/ | 200 | HTTP/2 200 |
#1 URL https://timeisnephrons.com:443
HTTP Status Code 301
Status HTTP/2 301
#2 URL https://LNknowthesigns.com
HTTP Status Code 301
Status HTTP/2 301
#3 URL https://www.lupkynispro.com/
HTTP Status Code 200
Status HTTP/2 200
Performance
| DNS Lookup | 33 ms |
| TCP Connect | 45 ms |
| TLS Handshake | 58.8 ms |
| Time To First Byte (TTFB) | 483.4 ms |
| Content Download | 88.6 ms |
| Total Response Time | 572 ms |
DNS Lookup 33 ms
TCP Connect 45 ms
TLS Handshake 58.8 ms
Time To First Byte (TTFB) 483.4 ms
Content Download 88.6 ms
Total Response Time 572 ms
Security
| HTTPS | ✔ Enabled |
| HSTS | ✔ max-age=31536000; includeSubDomains |
| CSP | ⚠ Not configured |
| X-Frame-Options | ✔ SAMEORIGIN |
| X-Content-Type-Options | ✔ nosniff |
| Referrer Policy | strict-origin-when-cross-origin |
| HTTP/2 | ⚠ HTTP/1.1 |
HTTPS ✔ Enabled
HSTS ✔ max-age=31536000; includeSubDomains
CSP ⚠ Not configured
X-Frame-Options ✔ SAMEORIGIN
X-Content-Type-Options ✔ nosniff
Referrer Policy strict-origin-when-cross-origin
HTTP/2 ⚠ HTTP/1.1
SEO Quick Check
| Title | LUPKYNIS® (voclosporin) | A More Complete Response |
| Meta Description | Explore an FDA-approved oral treatment for adults with active lupus nephritis (LN). Official site for HCPs. See Prescribing Information. |
| Canonical | https://www.lupkynispro.com/ |
| Open Graph Title | LUPKYNIS® (voclosporin) – treatment for lupus nephritis (LN) |
| Open Graph Description | Explore an FDA-approved oral treatment for lupus nephritis (LN) |
| Open Graph Image | /images/lupkynispro-og.jpg |
| Twitter Card | summary |
| Twitter Title | Explore an FDA-approved oral treatment for lupus nephritis (LN) |
| Twitter Description | LUPKYNIS® (voclosporin) – treatment for lupus nephritis (LN) |
Title LUPKYNIS® (voclosporin) | A More Complete Response Meta Description Explore an FDA-approved oral treatment for adults with active lupus nephritis (LN). Official site for HCPs. See Prescribing Information. Canonical https://www.lupkynispro.com/ Open Graph Title LUPKYNIS® (voclosporin) – treatment for lupus nephritis (LN) Open Graph Description Explore an FDA-approved oral treatment for lupus nephritis (LN) Open Graph Image /images/lupkynispro-og.jpg Twitter Card summary Twitter Title Explore an FDA-approved oral treatment for lupus nephritis (LN) Twitter Description LUPKYNIS® (voclosporin) – treatment for lupus nephritis (LN) Detected Technologies
| Technology | Google Analytics Google Tag Manager |
Technology Google Analytics Google Tag Manager
HTTP Headers
| Date
| Sun, 30 Aug 2026 22:05:08 GMT |
| Content-type
| text/html; charset=UTF-8 |
| Strict-transport-security
| max-age=31536000; includeSubDomains |
| X-powered-by
| PHP/8.2.30 |
| Referrer-policy
| strict-origin-when-cross-origin |
| X-content-type-options
| nosniff |
| X-frame-options
| SAMEORIGIN |
| X-xss-protection
| 1; mode=block |
| X-azure-ref
| 20260830T220508Z-r196975fb5cdcdsdhC1AMSrv400000000w2g000000000b33 |
| X-cache
| CONFIG_NOCACHE |
Meta Tags
| Description | Explore an FDA-approved oral treatment for adults with active lupus nephritis (LN). Official site for HCPs. See Prescribing Information. |
| Viewport | width=device-width, initial-scale=1 |
| Evo:build | 1a054b47620 |
| Keywords | oral medication for lupus nephritis, voclosporin, LN, treatment of lupus nephritis, first line, standard of care, MMF, corticosteroids, renal response, proteinuria, CNI |
| Msapplication-TileColor | #ffffff |
| Msapplication-config | /favicon/browserconfig.xml |
| Theme-color | #ffffff |
Date Sun, 30 Aug 2026 22:05:08 GMT
Content-type text/html; charset=UTF-8
Strict-transport-security max-age=31536000; includeSubDomains
X-powered-by PHP/8.2.30
Referrer-policy strict-origin-when-cross-origin
X-content-type-options nosniff
X-frame-options SAMEORIGIN
X-xss-protection 1; mode=block
X-azure-ref 20260830T220508Z-r196975fb5cdcdsdhC1AMSrv400000000w2g000000000b33
X-cache CONFIG_NOCACHE
